SI-BONE, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US8257041090
USD
12.87
-0.18 (-1.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
MiMedx Group, Inc.
LeMaitre Vascular, Inc.
SI-BONE, Inc.
Stevanato Group SpA
Establishment Labs Holdings, Inc.
Tandem Diabetes Care, Inc.
Paragon 28, Inc.
Avanos Medical, Inc.
Myriad Genetics, Inc.
Quanterix Corp.
Owens & Minor, Inc.

Why is SI-BONE, Inc. ?

1
Poor long term growth as Operating profit has grown by an annual rate 5.99% of over the last 5 years
2
The company has declared Positive results for the last 9 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD -1.22 MM
  • NET PROFIT(HY) Higher at USD -10.72 MM
  • ROCE(HY) Highest at -12.91%
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -12.75%, its profits have risen by 41.8%
4
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -12.75% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to SI-BONE, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is SI-BONE, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
SI-BONE, Inc.
-12.75%
-0.04
47.56%
S&P 500
18.81%
0.98
19.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
22.20%
EBIT Growth (5y)
5.99%
EBIT to Interest (avg)
-13.19
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.64
Sales to Capital Employed (avg)
0.76
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.30
EV to EBIT
-18.11
EV to EBITDA
-22.95
EV to Capital Employed
7.28
EV to Sales
2.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-40.22%
ROE (Latest)
-12.64%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -1.22 MM

NET PROFIT(HY)

Higher at USD -10.72 MM

ROCE(HY)

Highest at -12.91%

RAW MATERIAL COST(Y)

Fallen by -0.96% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 7.41 times

OPERATING PROFIT(Q)

Highest at USD -3.9 MM

OPERATING PROFIT MARGIN(Q)

Highest at -8.01 %

EPS(Q)

Highest at USD -0.11

-2What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at -63.27 %

Here's what is working for SI-BONE, Inc.

Operating Cash Flow
Highest at USD -1.22 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit
Higher at USD -10.72 MM
than preceding 12 month period ended Sep 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Operating Profit
Highest at USD -3.9 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at -8.01 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

EPS
Highest at USD -0.11
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Debtors Turnover Ratio
Highest at 7.41 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -0.96% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 1.49 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for SI-BONE, Inc.

Debt-Equity Ratio
Highest at -63.27 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio